Skip to main content
Harrison.ai logo

Harrison.ai

Updated Mar 24, 2026

How Harrison.ai stacks up in AI Healthcare — funding data, key investors, and more.

🇦🇺AustraliaSeries CAI Healthcare

Out of 100

🇦🇺

HQ

Australia

🗓

Founded

2018

💰

Raised

$129M

🏷️

Stage

Series C

👥

Team

100-500

Harrison.ai develops AI radiology and pathology analysis software for clinical deployment, building FDA-cleared and TGA-registered algorithms for chest X-ray abnormality detection, CT pulmonary angiography analysis, and mammography screening under its Annalise.ai product brand. The Sydney company focuses on AI clinical decision support that helps radiologists prioritise worklists, detect

Is this your company? Claim it →

Key Facts

  • Harrison.ai has raised a total of $129M in disclosed funding across 1 funding rounds.
  • Harrison.ai was founded in 2018 by Aengus Tran and is headquartered in Australia.
  • Harrison.ai employs approximately 100-500 people.
  • Harrison.ai operates in the AI Healthcare category and is currently at the Series C stage.
  • Harrison.ai has an Awaira Score of 68/100, ranking it among the tracked AI companies on Awaira.
  • Harrison.ai's most recent funding round was a Series C of $112M closed in February 2025, led by HESTA.

Source: Awaira · Updated Mar 24, 2026

N/A

Post-money

$129M

All rounds

68/100

2018

100-500 employees

Strengths

Strong Awaira Score of 68/100

Large team of 100-500+ employees

Late-stage with proven business model

Considerations

!

Valuation not publicly disclosed

Analysis based on publicly available data. Not investment advice.

⚠️ ESTIMATE
💵Est. Annual Revenue
$20M–$100M estimated ARR

Awaira estimate based on public data. Not financial advice.

How does Harrison.ai stack up against competitors?

MetricHarrison.aiButterfly NetworkTempusAlan
Awaira Score68/10085/10084/10083/100
Total Raised$129M$370M$1.05B$750M
ValuationN/A$957M$8.1B$5.83B
StageSeries CPublicPublicSeries D
Founded2018201120152016
Employees100-500500-10002500500-1000
Country🇦🇺🇺🇸🇺🇸🇫🇷
A

Aengus Tran

Founder & CEO

View founder profile →
StageSeries C
Employees100-500
Country🇦🇺 Australia
Connect
HESTABlackbird VenturesSkip Capital
Quiet
1 round
Series CLatest

Led by HESTA

$112M

Feb 2025

Frequently Asked Questions

What is Harrison.ai's valuation?
Valuation data is currently unavailable. The company may disclose this figure when it announces its next funding round.
Who invested in Harrison.ai?
On the cap table: HESTA, Blackbird Ventures, Skip Capital. Their combined backing has helped fund operations and expansion.
When did Harrison.ai last raise funding?
Capital was most recently raised through a Series C of $112M in February 2025. The round was led by HESTA.
How many employees does Harrison.ai have?
The team is roughly 100-500 people, headquartered in Australia.
What does Harrison.ai do?
Harrison. ai develops AI radiology and pathology analysis software for clinical deployment, building FDA-cleared and TGA-registered algorithms for chest X-ray abnormality detection, CT pulmonary angiography analysis, and mammography screening under its Annalise. Founded in 2018, Harrison.ai is categorized under AI Healthcare.
Who founded Harrison.ai?
Behind the company is Aengus Tran, who got it off the ground in 2018 in Australia. Aengus Tran serves as Founder & CEO.
Is Harrison.ai profitable?
Whether the company is profitable hasn't been confirmed publicly. It has raised $129M in total funding and is classified at the Series C stage.
Where is Harrison.ai headquartered?
Home base is Australia 🇦🇺. The AI Healthcare company was founded in 2018 and operates from there.
⚔️

Compare Harrison.ai

See how Harrison.ai stacks up against competitors in valuation, funding, team size, and Awaira Score.

Browse all comparisons →